Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
63M
-
Shares change
-
-3.82M
-
Total reported value, excl. options
-
$650M
-
Value change
-
-$41.8M
-
Put/Call ratio
-
0.65
-
Number of buys
-
46
-
Number of sells
-
-59
-
Price
-
$10.32
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2015
149 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q4 2015.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63M shares
of 210M outstanding shares and own 30.06% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (14.2M shares), FMR LLC (7.49M shares), WELLINGTON MANAGEMENT GROUP LLP (7.47M shares), RA CAPITAL MANAGEMENT, LLC (3.09M shares), VANGUARD GROUP INC (2.81M shares), BlackRock Fund Advisors (2.79M shares), D. E. Shaw & Co., Inc. (2.57M shares), STATE STREET CORP (2.11M shares), RTW INVESTMENTS, LLC (2.01M shares), and BlackRock Institutional Trust Company, N.A. (1.81M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.